Surgery With or Without Chemotherapy for Stage I NSCLC With Micropapillary Component ≥ 20%

Clinical trial NCT03351842 · RECRUITING

Trial details

NCT number: NCT03351842
Sponsor: Shanghai Pulmonary Hospital, Shanghai, China
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Chemotherapy, Adjuvant Lung Adenocarcinoma, Stage I Treatment Histological Type of Neoplasm

Start date: 2017-09-01
Primary completion: 2019-09-01
Enrollment: 460

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.